Preparation and Olfactory Characterization of the Enantiomerically Pure Isomers of the Perfumery Synthetic Galaxolide

The commercially important isochromane musk odorant Galaxolide® (=1,3,4,6,7,8‐hexahydro‐4,6,6,7,8,8‐hexamethylcyclopenta[g]‐2‐benzopyran; HHCB; 3) was separated into its diastereoisomers via the tricarbonyl(η6‐cyclopenta[g]‐2‐benzopyran)chromium complexes 10. Since GC/olfactometry indicated that onl...

Full description

Saved in:
Bibliographic Details
Published inHelvetica chimica acta Vol. 82; no. 10; pp. 1656 - 1665
Main Authors Fráter, Georg, Müller, Urs, Kraft, Philip
Format Journal Article
LanguageEnglish
Published Basel Verlag Helvetica Chimica Acta 06.10.1999
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The commercially important isochromane musk odorant Galaxolide® (=1,3,4,6,7,8‐hexahydro‐4,6,6,7,8,8‐hexamethylcyclopenta[g]‐2‐benzopyran; HHCB; 3) was separated into its diastereoisomers via the tricarbonyl(η6‐cyclopenta[g]‐2‐benzopyran)chromium complexes 10. Since GC/olfactometry indicated that only one enantiomer of each diastereoisomer (4RS,7RS)‐3 and (4RS,7SR)‐3 determines the odor characteristics of the commercial product, all four stereoisomers (4S,7R)‐, (4S,7S)‐, (4R,7S)‐, and (4R,7R)‐3 were synthesized by Friedel‐Crafts alkylation of 1,1,2,3,3‐pentamethylindane (11) with (S)‐ and (R)‐methyloxirane ((S)‐ and (R)‐12, resp.), acid‐catalyzed reaction of the resulting products with paraformaldehyde, and separation of the formed diastereoisomer pairs via the tricarbonyl(η6‐cyclopenta[g]‐2‐benzopyran)chromium complexes 10. The powerful musk odor of Galaxolide ® (3) was thus attributed to its (−)‐(4S)‐isomers (4S,7R)‐ and (4S,7S)‐3, while the (+)‐(4R)‐isomers (4R,7S)‐ and (4R,7R)‐3 were weak to almost odorless.
Bibliography:istex:DC9927E74CA81B83D96110EBA97C4C3669EC54B2
ArticleID:HLCA1656
ark:/67375/WNG-XMZHPMWC-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0018-019X
1522-2675
DOI:10.1002/(SICI)1522-2675(19991006)82:10<1656::AID-HLCA1656>3.0.CO;2-M